Technical Analysis for CSCI - COSCIENS Biopharma Inc.

Grade Last Price % Change Price Change
F 4.060 -3.33% -0.140
CSCI closed down 3.33 percent on Thursday, November 21, 2024, on 5.65 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Volume Surge Other 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Hammer Candlestick Bullish -3.33%
Volume Surge Other -3.33%
Calm After Storm Range Contraction -3.33%

   Recent Intraday Alerts

Alert Time
New 52 Week Low about 9 hours ago
Gap Down Partially Closed about 11 hours ago
Gapped Down (Partial) about 12 hours ago
Down 1 ATR about 12 hours ago
Fell Below Previous Day's Low about 12 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

COSCIENS Biopharma Inc. Description

COSCIENS Biopharma Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis. The company also has a license and research agreement with University of Wuerzburg to develop, manufacture, and commercialize AIM biologicals for the treatment of neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. In addition, it has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults; as well as The University of Sheffield, the United Kingdom for the development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of chronic hypoparathyroidism. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is headquartered in Toronto, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Diagnostic Tests Macimorelin Parkinson's Disease Peptide Hormones Tryptamines

Is CSCI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.0
52 Week Low 3.78
Average Volume 1,823
200-Day Moving Average 0.000
50-Day Moving Average 5.027
20-Day Moving Average 4.681
10-Day Moving Average 4.353
Average True Range 0.286
RSI (14) 33.77
ADX 44.48
+DI 8.761
-DI 37.075
Chandelier Exit (Long, 3 ATRs) 4.344
Chandelier Exit (Short, 3 ATRs) 4.637
Upper Bollinger Bands 5.450
Lower Bollinger Band 3.912
Percent B (%b) 0.1
BandWidth 32.860
MACD Line -0.299
MACD Signal Line -0.260
MACD Histogram -0.0384
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.480
Resistance 3 (R3) 4.433 4.247 4.410
Resistance 2 (R2) 4.247 4.140 4.270 4.387
Resistance 1 (R1) 4.153 4.074 4.200 4.200 4.363
Pivot Point 3.967 3.967 3.990 3.990 3.967
Support 1 (S1) 3.873 3.860 3.920 3.920 3.757
Support 2 (S2) 3.687 3.794 3.710 3.733
Support 3 (S3) 3.593 3.687 3.710
Support 4 (S4) 3.640